Keywords: b-ms, launch, taxol, unreimbursed, japan, bristol-myers, squibb

B-MS To Launch Taxol, Unreimbursed, In Japan

Article | 25 September 1997

Print This

Bristol-Myers Squibb KK, the Japanese subsidiary of B-MS, will launchits ovarian cancer drug Taxol (paclitaxel) onto the Japanese market on ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in